Controversial statistical issues in clinical trials [electronic resource]

• 作者： Chow, Shein-Chung, 1955-
• 其他題名：
  • Chapman & Hall/CRC biostatistics series.
• 出版： Boca Raton : CRC Press
• 叢書名： Chapman & Hall/CRC biostatistics series
• 主題： Drugs--Testing. , Drug development. , Clinical trials. , Clinical Trials as Topic. , Drug Evaluation, Preclinical. , Data Interpretation, Statistical.
• ISBN： 9781439849620 (electronic bk.)
• FIND@SFXID: CGU
• 資料類型: 電子書
• 課程: 進階臨床試驗 ( 臨醫所碩士班臨資組 - 林志榮)
  進階臨床試驗 ( 臨醫所碩士班臨醫組 - 林志榮)
• 內容註: Includes bibliographical references (p. 553-575) and index.
• More
• 摘要註: "Preface In pharmaceutical/clinical development of a test drug or treatment, relevant clinical data are usually collected from subjects with the diseases under study in order to evaluate safety and efficacy of the test drug or treatment under investigation. To provide accurate and reliable assessment, well-controlled clinical trials under valid study design are necessarily conducted. Clinical trial process is a lengthy and costly process, which is necessary to ensure a fair and reliable assessment of the test treatment under investigation. Clinical trial process consists of protocol development, trial conduct, data collection, statistical analysis/interpretation, and reporting. In practice, controversial issues evitably occur regardless the compliance of good statistical practice (GSP) and good clinical practice (GCP). Controversial issues in clinical trials are referred to as debatable issues that are commonly encountered during the conduct of clinical trials. In practice, controversial issues could be raised from, but are not limited to, (1) compromises between theoretical and real/common practices, (2) miscommunication and/or misunderstanding in perception/interpretation among regulatory agencies, clinical scientists, and biostatisticians, and (3) disagreement, inconsistency, miscommunication/misunderstanding, and errors in clinical practice. "--
• 讀者標籤：

  需登入
• 引用連結：

  Copy Link
• 目前引用數
• Share: